Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil as Adjunct to Escitalopram in Major Depressive Disorder
NCT04344678Withdrawn
- Sponsor
- Sadat City University
- Start
- Jan 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ASP-001 in major depressive disorder (MDD) (2 arms), sponsored by Sadat City University. Primary endpoint: Hamilton Depression Rating Scale at 12 weeks. Planned start Jan 2020; status: withdrawn.
02
Drugs
ASP-001
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04344678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04344678.